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Mucin Hypersecreting Intraductal Papillary Neo-
plasm is a rare neoplasm that arises from ductal
epithelial cells. This entity is distinct from the more
commonly known Mucinous Cystadenoma or Mu-
cinous Cystadenocarcinoma. Despite this distinc-
tion, it has been erroneously categorized with these
more common cystic neoplasms. Characteristic clin-
ical presentation, radiographic, and endoscopic
findings help distinguish this neoplasm from the
cystadenomas and cystadenocarcinomas. Histo-
pathologic identification is not crucial to the
preoperative diagnosis. This neoplasm is considered
to represent a premalignant condition and, there-
fore, surgical resection is warranted. Prognosis,
following resection, is felt to be curative for the
majority of patients.
We present two cases of Mucin Hypersecreting
Intraductal Papillary Neoplasm and discuss their
diagnosis and surgical therapy.
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plasm, cystic neoplasm, pancreas
INTRODUCTION
Mucin Hypersecreting Intraductal Papillary
Neoplasm is a distinct entity from the more
commonly known Mucinous Cystadenoma or
Mucinous Cystadenocarcinoma. It has been
referred to by many other names including
mucinous duct ectasia, intraductal papillary
neoplasm or adenocarcinoma, ductectatic-type
or variant of mucinous cystadenoma or muci-
nous cystadenocarcinoma, multiple primitive
endoluminal tumors of the main pancreatic duct
of Wirsung, diffuse villous carcinoma of the duct
of Wirsung, carcinoma in situ of the pancreas,
and intraductal mucin hypersecreting neo-
plasms or carcinomas [1-6]. This neoplasm is
characterized by dilatation of the main pancrea-
tic duct of Wirsung and the secondary ducts
with the production of mucin and by its
malignant potential [1,3,5]. Because of this
malignant potential, surgical therapy is war-
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ranted in appropriate patients. Unlike the dis-
appointing results with surgery encountered
with the more common adenocarcinomas of
the pancreas, surgery for this neoplasm is
associated with a very good outcome.
CASE REPORTS
Case 1
A 73-year old woman presented with a four year
history of post-prandial abdominal pain. Inter-
estingly, her older sister died recently from
pancreatic cancer. Her mother was a diabetic
and had ovarian cancer, another sister had colon
cancer, and her brother had prostate cancer. The
patient quit smoking 40 years ago and maintains
minimal alcohol use. The patient presented to
her primary physician with worsening of her
symptoms in 1996 and associated five pound
weight loss. An ultrasound of the gallbladder
demonstrated no cholelithiasis, but there was
lymphadenopathy in the perigastric region.
Computed tomography (CT) showed a cystic
mass within the pancreatic head measuring 6cm
in length and a 2cm density along the inferior
aspect of the pancreas (Fig. 1). An endoscopic
retrograde cholangiopancreatography (ERCP)
examination revealed mucin extruding from
the ampulla and ductal dilatation with an
irregular strictured segment near the junction
of the head and the body (Fig. 2). Preoperative
Carcinoembryonic Antigen (CEA) was found to
be 1.5 ng/mL (Normal < 2.5 ng/mL nonsmoker,
< 5.0 ng/mL smoker) and Carbohydrate Antigen
19-9 was 12U/mL (Normal <31U/mL). Liver
enzymes were within normal limits. Amylase
was elevated at 256U/L and glucose was mildly
elevated at 131 mg/dL. She underwent a pylorus
preserving pancreaticoduodenectomy. On gross
examination, mucin extruded from the ampulla
and on cross section the pancreatic ducts were
more distended with mucin into cyst-like spaces
(Figs. 3a-b). Frozen section confirmed tumor
free margins. The patient had an uneventful
post-operative course and was doing well at six
months follow up. The final pathology of the
mass indicated a Mucin Hypersecreting Intra-
ductal Papillary Neoplasm of the pancreas with
FIGURE Case #1 CT of abdomen demonstrating a cystic mass within the pancreatic head (arrow).FIGURE 2 Case #1 ERCP demonstrating ductal dilatations with an irregular strictured segment near the junction of the head
and the body.
a
FIGURE 3 Case #1 Gross picture of Mucin Hypersecreting Intraductal Papillary Neoplasm. (a) Cross section of main duct with
extrusion of viscous mucin (large arrow). Note absence of intraluminal masses and involvement of smaller branch ducts (small
arrow). (b) Mucin extruding through dilated ampulla (arrow). (See Color Plate III).178 A.W. KIM et al.
FIGURE 3
5% of the total area showing severe dysplasia or
adenocarcinoma in situ. No invasion was seen.
There was evidence of extravasation of mucin
into the pancreatic stroma resulting in extensive
sclerosis. There was also generalized periductal
fibrosis and significant chronic pancreatitis.
Margins were read as without atypia and the
peripancreatic lymph nodes were free of tumor.
Histologically, the duct of Wirsung and its
branches showed ectasia and papillary hyper-
plasia of the epithelium along with luminal
mucin (Figs. 4a-d).
Case 2
A 76-year old woman presented with three
episodes of .pancreatitis, the last visit with an
elevated Amylase (236 U/L) and Lipase (361 U/
L). There was no abdominal pain, nausea,
emesis, or weight loss. Previous medical history
included hepatitis B virus infection, hyperten-
sion, and gastroesophageal reflux disease. Sur-
(Continued).
gical history was significant for ovarian cyst
removal, total abdominal hysterectomy, and a
Marshal- Marchetti- Kranz procedure for urin-
ary incontinence. There was either history of
tobacco or ethanol use nor any significant family
history. CT scan demonstrated diffuse pancrea-
tic ductal dilatation but no masses or nodes (Fig.
5). An ERCP demonstrated a dilated major
pancreatic duct with filling defects in the head
of the pancreas (Fig. 6) and endoscopic exam-
ination revealed a patulous major papilla (Fig.
7). A sphincterotomy followed by brush cytol-
ogy revealed benign cells. Measurements of
CEA and CA 19-9 six months earlier were
6.9 ng/mL and < 8U/mL, respectively. One
month later, CEA rose to 8.4ng/mL while CA
19-9 remained at < 8U/mL. Liver enzymes were
within normal limits. Pancreaticoduodenectomy
was performed. Intraoperatively, the presumed
involved region of the pancreas was removed
and sent to pathology. The cut margin revealed
papillary mucinous epithelium at the ducta
FIGURE 4 Case #1 Pathology Slides: (a) Low power view showing the lumen of a duct filled with papillary epithelium. (b)
Papillae lined by tall columnar, mucin secreting cells with basally oriented nuclei. Goblet cells are seen. (c) Area of severe
dysplasia (arrows). (d) Area of fibrotic pancreatic parenchyma (small arrow) with dissection of mucin (large arrow). (See Color
Plate IV)..180 A.W. KIM et al.
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FIGURE 5 Case #2 CT of abdomen demonstrating diffuse pancreatic ductal dilatation, but no masses or lymphadenopathy
(arrows).
FIGURE 6 Case #2 ERCP showing a dilated major pancreatic duct with filling defects in the head of the pancreas.182 A.W. KIM et al.
FIGURE 7 Case #2 endoscopic picture demonstrating ERCP cannula placed through characteristic finding of a patulous
papillae. (See Color Plate V).
margin necessitating a further 2.5 cm resection of
the neck of the pancreas that revealed no further
neoplasm. The postoperative course was unre-
markable. Final pathology confirmed Mucin
Hypersecreting Intraductal Papillary Neoplasm
of the pancreas without invasion or lymph node
involvement and with extensive duct ectasia.
Foci of moderate dysplasia, papillary duct
epithelial hyperplasia, periductal sclerosis and
chronic pancreatitis were observed. The addi-
tional resected neck of the pancreas showed duct
ectasia, periductal sclerosis, and focal chronic
pancreatitis, but no dysplasia or neoplasm.
DISCUSSION
Mucin hypersecreting intraductal neoplasms
were first described as a separate neoplastic
entity in 1982 [3,7,8]. The exact frequency of
occurrence is unknown, although an estimation
of 1% has been reported [9,10]. A review of the
literature indicates uncertainty regarding a sex
bias and age predilection [1,4,6]. The cystic
nature of this entity has led to the mistaken
classification of this tumor with the more
common mucinous cystic tumors, Mucinous
Cystadenoma and Mucinous Cystadenocarcino-
mas [1,3,9]. Although these neoplasms are
considered cystic neoplasms they differ from
the typical cystadenomas and cystadenocarcino-
mas by their clinical presentation and pathology.
Epidemiologically, mucinous cystic tumors oc-
cur in younger patients with a predominance in
females. Additionally, mucinous cystadenomas
often originate in the tail whereas the Mucin
Hypersecreting Intraductal Papillary Neoplasms
tend to originate in the head.
The clinical presentation can include epigas-
tric discomfort or severe pain sometimes asso-
ciated with steatorrhea or weight loss [1,8].
Jaundice, cholangitis, and diabetes mellitus havePAPILLARY NEOPLASM OF THE PANCREAS 183
also been described [1, 7,8]. Obstructive jaundice
may occur secondary to ductal mucin impaction
or ampulla involvement when fistulas form into
the bile duct or duodenum [1,7]. Increased
amylase and lipase levels presumably are due
to the pancreatitis that occurs in approximately
50-100% of the cases. These elevations are
thought to be secondary to the mucin plugging
of the ducts and the presence of intraluminal
masses [3, 4]. The pancreatitis may be acute or
chronic and may result in exocrine and endo-
crine pancreatic insufficiency [1,3,5,6]. The
finding of dilated ducts alone makes the
distinction from chronic pancreatitis a difficult
one [11]. Incidental discovery of this neoplasm
in asymptomatic patients is another possible
clinical presentation [1].
Grossly, the ectatic duct surfaces are either
smooth and filled with mucin or contain
papillary growths. Mucin within the ducts may
be difficult to drain and can predispose the
ducts to mucin plug formation that may ulti-
mately lead to ductal dilation and pancreatitis
[4]. In contrast, the Mucinous Cystadenomas
and Cystadenocarcinomas have large dominant
loculations of mucin surrounded by a fibrotic
capsule [12] that, typically, do not communicate
with the ductal system unless there is a fistulous
formation between the two [9].
Histopathologically, the ducts are lined by a
single layer of tall columnar cells [1, 3, 4, 8]. The
surrounding pancreatic tissue can show perilob-
ular and intralobular fibrosis [3]. This fibrosis is
thought to be due to the leakage of the
hypersecreted mucin into the pancreatic par-
enchyma [5]. Mild epithelial dysplasia constitu-
tes the diagnosis of adenoma, whereas, severe
dysplasia constitutes intraductal carcinoma (car-
cinoma in situ) [10]. The prevalence of carcinoma
in situ or invasive lesions has been reported to be
as high as 88% [6].
Diagnosis of Mucin Hypersecreting Intraduc-
tal Papillary Neoplasm may be suggested by
ultrasound or CT when there is diffuse or
segmented dilatation of the main duct or when
there are intraluminal polypoid lesions. Con-
firmation is achieved by identifying character-
istic endoscopic and pancreatographic findings
[3, 7,11]. The finding of a patulous papilla with
drainage of frank mucin is highly suggestive of
the diagnosis. Confirmation by ERCP shows a
dilated Ampulla of Vater, or patulous papilla,
with significant main pancreatic duct dilatation
and intraluminal filling defects within the main
duct and, occasionally, the side branch ducts
[2-4, 6-8,11,13]. The sensitivity, specificity,
and accuracy of ERCP has been reported to be
91%, 91%, and 86% respectively [10]. Recently,
pancreatoscopy has been advocated in diagnos-
ing this neoplasm [3].
Imaging studies demonstrating increased tu-
mor size has been shown to correlate with
malignancy [2]. Although imaging studies can-
not definitively distinguish among hyperplasia,
adenoma, and adenocarcinoma, there have been
criteria reported, based upon tumor size, that
correlates with histopathologic tumor grade.
ERCP studies suggest that ductal dilation great-
er than 8mm in diameter have an increased
incidence of being adenocarcinoma. Endoscopic
ultrasound studies also suggest the same when
cystic lesions are greater than 20mm [13].
Recently, cytology has been emphasized for its
greater diagnostic role. Compared to an endo-
scopic ultrasound and an ERCP, cytology was
shown to have a higher sensitivity, specificity,
and accuracy in detecting malignancy [13].
Surgery can be delayed in patients without
cancerous cytology.
Overall, the prognosis of this neoplasm is very
good and given the low malignant potential,
resection, either by pancreaticoduodenectomy or
distal pancreatectomy depending upon the site
of the lesion, is recommended upon discovery.
In a few cases, total pancreatectomy, despite its
known sequelae, may be indicated [6,9]. The
good prognosis with resection is yet another
distinguishing characteristic of this neoplasm
when compared to the other cystic neoplasms
[1, 4,8]. Lymph node involvement is usually not184 A.W. KIM et al.
a factor, thus extensive nodal dissection is
usually not indicated. Follow up does not
include any special considerations as there have
been no data showing recurrence or metastatic
spread [1, 3, 4, 6].
The findings in this case report were consis-
tent both grossly and histologically with the
previously described mucinous duct ectatic
neoplasms. The patients in the two cases
reported had components of the classic presen-
tation of this neoplasm. Both had evidence of
chronic pancreatitis with elevations in either
amylase or lipase or both. Both patients had
diagnostic imaging tests highly suggestive of
Mucin Hypersecreting Intraductal Papillary
Neoplasm and as a result underwent a pancrea-
ticoduodenectomy. Gross examination of the
tumor intraoperatively, in both cases, demon-
strated expected changes and the pathologic
diagnosis confirmed the clinical suspicions and
imaging study findings. In both cases, the
outcomes of the pancreaticoduodenectomy were
uneventful and consistent with the good prog-
nosis afforded by this rare neoplasm. Given the
possibility of this neoplasm undergoing malig-
nant transformation, surgical therapy was not.
only recommended, but also warranted in the
two cases described.
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